Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534063 · ClinicalTrials.gov registry record · NA
Implementing Genomics in Practice (IGNITE): CYP2D6 Genotype-Guided Pain Management in Patients Undergoing Arthroplasty Surgery
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
NCT03534063 is a NA study that has completed, run by University of Florida. The registered enrollment target is 260 participants.
The verdict
NCT03534063, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
Study Summary
This will be a randomized, open-labeled pilot pragmatic clinical trial. Patients undergoing arthroplasty surgery will be recruited from the University of Florida (UF) Health Gainesville and the Villages Orthopedic clinics for CYP2D6 pharmacogenetic testing to manage post-surgical pain. Patients will be randomized 2:1 to either usual care or genotype-guided care. The aims of the study were to: 1) test the feasibility of a genotype-guided opioid prescribing approach for patients undergoing an outpatient surgical procedure, a group at high risk for persistent opioid use; and 2) evaluate the effect of genotype-guided post-surgical pain management on pain control and opioid prescribing.
Interventions
- GENETIC CYP2D6-guided opioid therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2018-06-07 |
| Est. Completion | 2020-04-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03534063
The ClinicalTrials.gov registry entry for NCT03534063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CYP2D6-guided opioid therapy is the first listed.
NCT03534063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03534063 about?
NCT03534063 is a clinical study titled "Implementing Genomics in Practice (IGNITE): CYP2D6 Genotype-Guided Pain Management in Patients Undergoing Arthroplasty Surgery". This will be a randomized, open-labeled pilot pragmatic clinical trial. Patients undergoing arthroplasty surgery will be recruited from the University of Florida (UF) Health Gainesville and the Villages Orthopedic clinics for CYP2D6 pharmacogenetic testing to manage post-surgical pain. Patients will...
What is the current status of trial NCT03534063?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2018-06-07. Estimated completion is 2020-04-29.
What interventions are being tested in trial NCT03534063?
The interventions under investigation include: CYP2D6-guided opioid therapy (GENETIC).
Who is sponsoring clinical trial NCT03534063?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.